News from NIAID-Supported Institutions
National Institute of Allergy and Infectious Diseases sent this bulletin at 11/15/2012 03:54 PM ESTHere’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:
Game Changer for Arthritis, Anti-Fibrosis Drugs
November 12, 2012—University of Utah
UNC, Vanderbilt Discover a New Live Vaccine Approach for SARS and Novel Coronaviruses
November 12, 2012—Vanderbilt University
BioCryst Broad-Spectrum Antiviral BCX4430 Highly Effective against Yellow Fever in a Preclinical Disease Model
November 12, 2012—BioCryst Pharmaceuticals, Inc.
These news releases were issued by organizations supported by NIAID. To receive NIAID-issued news releases, update your subscription preferences by selecting “News Releases.”
Game Changer for Arthritis, Anti-Fibrosis Drugs
November 12, 2012—University of Utah
UNC, Vanderbilt Discover a New Live Vaccine Approach for SARS and Novel Coronaviruses
November 12, 2012—Vanderbilt University
BioCryst Broad-Spectrum Antiviral BCX4430 Highly Effective against Yellow Fever in a Preclinical Disease Model
November 12, 2012—BioCryst Pharmaceuticals, Inc.
These news releases were issued by organizations supported by NIAID. To receive NIAID-issued news releases, update your subscription preferences by selecting “News Releases.”
.png)
No hay comentarios:
Publicar un comentario